Aygestin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Women's Health, Inc.. The primary component is Norethindrone Acetate.
Product ID | 51285-424_06e80ebe-6a25-4bf2-806b-b786b001141a |
NDC | 51285-424 |
Product Type | Human Prescription Drug |
Proprietary Name | Aygestin |
Generic Name | Norethindrone Acetate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2003-06-12 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA075951 |
Labeler Name | Teva Women's Health, Inc. |
Substance Name | NORETHINDRONE ACETATE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2003-06-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA075951 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2003-06-12 |
Marketing Category | ANDA |
Application Number | ANDA075951 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2003-06-12 |
Marketing End Date | 2010-08-02 |
Ingredient | Strength |
---|---|
NORETHINDRONE ACETATE | 5 mg/1 |
SPL SET ID: | 69f5bc4b-758d-471b-ad8d-17c94f8e0963 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
51285-424 | Aygestin | Norethindrone Acetate |
0179-0227 | Norethindrone Acetate | Norethindrone Acetate |
0378-7291 | Norethindrone Acetate | Norethindrone Acetate |
0555-0211 | Norethindrone Acetate | Norethindrone Acetate |
16571-658 | Norethindrone acetate | norethindrone acetate |
50742-267 | Norethindrone acetate | norethindrone acetate |
65862-715 | Norethindrone acetate | Norethindrone acetate |
68462-304 | Norethindrone Acetate | Norethindrone Acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AYGESTIN 73304330 1202507 Live/Registered |
American Home Products Corporation 1981-04-03 |